WTWan-Yee Tang

Wan-Yee Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wan-Yee Tang has a total of 312 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Large‐Scale Protein Assay Identifies Novel Protein Biomarkers Associated With Arterial Stiffness and Vascular Calcification Measures

    by Rain Katz, Ryan Cvejkus, Jiebiao Wang, Bharat Thyagarajan, Emma Barinas-Mitchell, John Jeffrey Carr, James G. Terry, Sangeeta Nair, Winnie Wan-Yee Tang, Rachel G. Miller, et al.

    Large‐scale protein assays have the potential to identify novel biomarkers and improve prediction of cardiovascular disease (CVD) risk. The burden of atherosclerotic CVD and related risk factors is disproportionately high in Afro‐Caribbean populations in whom novel risk prediction strategies may be warranted. Thus, we analyzed the association of early atherosclerosis markers with peripheral blood proteomic biomarkers quantified using the Olink Target 96 Cardiovascular III panel in 342 community‐dwelling men from the Tobago Health Study. Atherosclerosis markers included pulse wave velocity (PWV), abdominal aortic calcification (AAC), and coronary artery calcification (CAC). Blood pressure, height, and weight were measured by trained clinic staff. Hypertension, dyslipidemia, and diabetes status were classified via clinical measures and the prescription of relevant medication. Statistical methods included differential expression analysis fully adjusted for assay batch, age, BMI, smoking, diabetes, dyslipidemia, and blood pressures. Men ranged from 53 to 89 years of age (mean ± SD = 63.3 ± 8.1 years). Average BMI was 27.7 ± 4.3 kg/m 2 , 79.2% had hypertension, average LDL cholesterol was 129.4 ± 37.7 mg/dL, 24.6% had diabetes, and 5.9% were current smokers. In fully adjusted models, 18 proteins were associated with PWV and 1 was associated with CAC. There were no significant associations with AAC. Thirteen of these significant associations (12 PWV and 1 CAC) were novel, having never been identified as associated with these atherosclerosis measures in any previous study. While these proteins are involved in physiological processes known to contribute to CVD, such as inflammation, the strongest effects were seen for previously unreported protein associations. Our work is the first large‐scale protein assay performed in an Afro‐Caribbean population and adds to existing evidence that indicates that protein biomarker signatures of CVD may differ by racial/ethnic group. Further research is needed to understand the role of protein biomarkers in the prediction and progression of CVD among this high‐risk group.

  • Open Access

    Toxicogenomic Insights into Environmental Toxicant Exposures: The TaRGET II Resource

    by Bo Zhang, Benpeng Miao, Shuhua Fu, Cristian Coarfa, Ravindra Kumar1, Prashant Kuntala, Bongsoo Park, Sandra Grimm, Rahul Jangid, Justin Colacino, et al.

    Environmental exposures to toxic chemicals can profoundly alter the transcriptome and epigenome in both humans and animals, contributing to disease development across the lifespan. To elucidate how early-life exposure to toxicants exerts such persistent effects, the Toxicant Exposures and Responses by Genomic and Epigenomic Regulators of Transcription II (TaRGET II) Consortium generated a landmark resource comprising 2,570 epigenomes and 1,043 transcriptomes from longitudinal studies in mice. All data are publicly available through the TaRGET II data portal and the WashU Epigenome Browser. This resource from target (liver, brain, lung, heart) and surrogate (blood) tissues at weaning (3 weeks) and two adult time-points (5 and 10 months) characterized the molecular response to arsenic (As), lead (Pb), bisphenol-A (BPA), di-2-ethylhexyl phthalate(DEHP), tributyltin (TBT), tetrachlorodibenzo-p-dioxin (TCDD), and particulate matter with a diameter of <2.5μm (PM2.5). The findings revealed persistent, toxicant-specific, sex-dependent epigenomic and transcriptomic perturbations, resulting in disrupted expression of 14,908 genes, altered chromatin accessibility at 87,409 regulatory elements, DNA methylation changes at 113,186 genomic regions, and chromatin state switching of histone modifications. The resulting high-resolution map of how environmental exposures reprogram the epigenome and transcriptome is broadly accessible via ToxiTaRGET database, offering unparalleled opportunities for the scientific community to investigate the molecular underpinnings of environmental toxicant exposures and their contributions to disease pathogenesis.

  • Open Access

    Early-life Exposure to Arsenic Primes the Offspring to Increased Asthma Risk: Transcriptome and Epigenome Analysis

    by Yuchen Sun, Musa Watfa, Qin-Ying Sun, Dhivyaa Rajasundaram, Ben Schlegel, Hoi-Yee. Yeung, Jarius Pulczinski, Bongsoo Park, Aaron Barchowsky, Wayne Mitzner, et al.

    Inorganic arsenic (iAs) in drinking water is a global health concern. This study tests whether maternal exposure to iAs in drinking water at the WHO provisional level (10µg/L) increases offspring asthma risk via epigenetic reprogramming. F1 mice prenatally exposed to iAs were analyzed at 5 months for blood transcriptome and methylome changes and challenged with house allergens before lung function testing. Prenatal iAs exposure led to increased airway hyperresponsiveness (AHR) and altered inflammation gene expression and DNA methylation changes. Notably, miR-101c was epigenetically reprogrammed early in development, with persistent downregulation in both target (fetal and adult lungs) and surrogate (amniotic fluid and blood) tissues. These changes correlated with increased allergic AHR and TGFβ pathway dysregulation. Findings suggest that maternal iAs exposure primes offspring for asthma risk through epigenetic alterations and may inform risk assessment and biomarker development in affected communities. KEY FINDINGS: In utero exposure to 10 part per billion (or 10 µg/L, the current WHO and EPA provisional level in drinking water) inorganic arsenic (iAs) increases offspring asthma risk. These results raise concerns about the current safety thresholds for iAs in drinking water (Fig. 1). Transcriptomic and methylome analyses of blood leukocytes from 5-month-old F1 mice revealed that maternal iAs exposure induces transcriptional changes in genes related to allergic airway responses. Pathway analysis highlighted the involvement of miR-101c and its connection with TGFβ downstream targets in regulating extracellular matrix signaling, embryonic development, and inflammatory (Figs. 2 and 3). Transcriptional changes in c ol3a1 and miR-101c in blood were strongly correlated with allergen-induced airway hyperresponsiveness (AHR), with similar alterations detected in plasma samples. These findings provide new insights into respiratory health in affected communities and support the development of biomarkers for iAs risk assessment (Figs. 4 and 5). Several gene-specific epigenetic alterations induced by early-life iAs exposure were consistently observed in both surrogate (blood) and target (lung) tissues across developmental stages, offering new panels of easily accessible markers for early detection and monitoring of lung disease risk in offspring. The persistence of these markers over time makes them valuable for predictive modeling and life course studies. (Fig. 6). Downregulation of miR-101c was validated in fetal lung and amniotic fluid of the iAs-exposed group, suggesting that epigenetic reprogramming of miR-101c is initiated early in gestation (Fig. 7). These findings help uncover causal pathways linking environmental exposures to asthma pathogenesis. Distinct sex-specific patterns in blood transcriptome and methylome alterations in respond to early-life iAs exposure underscore the importance of considering sex as a biological variable in omics research. GRAPHIC Description: F1 progeny prenatally exposed to iAs were assessed for blood transcriptomic and DNA methylome analysis at 5 months of age. Correlation analysis between transcriptional changes and allergen-induced airway hyperresponsiveness (AHR) was conducted to examine the epigenetic impact of maternal iAs exposure on offspring asthma risk.

  • Open Access

    An assessment of maternal concentrations of per- and polyfluoroalkyl substances (PFAS) and trace elements during the second trimester of pregnancy in western Pennsylvania

    by Natalie F. Price, Alexis Kiyanda, Wan-Yee Tang, Zachary Zimmerman, Janet Catov, Aaron Barchowsky, Aubrey L. Galusha, Kurunthachalam Kannan, Elizabeth J. Mullin, Patrick J. Parsons, et al.

    Exposure to trace elements and per- and polyfluoroalkyl substances (PFAS) during pregnancy is linked to adverse reproductive and developmental outcomes. High smoking rates in western Pennsylvania may influence exposure to these chemicals. We characterized PFAS, trace element, and smoking exposure in the second trimester of pregnancy among women in western Pennsylvania. We measured 38 urine trace elements and 11 serum PFAS in 46 pregnant women in 2017–2021 as part of a nested pilot study from the Magee Obstetric Maternal and Infant (MOMI) biobank and database. We statistically compared environmental chemical concentrations between smoking and non-smoking participants in the MOMI pilot study. Additionally, we descriptively compared MOMI concentrations to a nationally representative sample of US women of reproductive age from the National Health and Nutrition Examination Survey (NHANES) and to published studies characterizing exposures among international populations. Two PFAS (PFOA and PFOS) and 16 trace elements were highly detected in the MOMI pilot study sample. Smoking participants had distributions of 10 trace element concentrations that tended to be significantly higher compared to non-smoking participants, but no significant differences in the distributions of serum PFAS concentrations. All participants had summed PFAS concentrations > 2 μg/L—the National Academies of Sciences Engineering and Medicine threshold for recommending additional health screening. MOMI non-smoking participants had higher concentrations of seven trace elements and lower concentrations of both PFAS compared with NHANES non-smoking participants, while MOMI smoking participants had higher concentrations of 12 trace elements and lower concentrations of both PFAS compared with NHANES smoking participants. Further research is necessary to identify the sources of exposure, potential health effects, and effective strategies to reduce exposure to these environmental chemicals.


  • Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary Disease

    by Bonnie H. Yeung-Luk, Ara Wally, Carter Swaby, Sofia Jauregui, Esther Lee, Rachel Zhang, Daniel Chen, Sean H. Luk, Nisha Upadya, Ethan Tieng, et al.

    Chronic obstructive pulmonary disease (COPD) remains a major public health challenge that contributes greatly to mortality and morbidity worldwide. Although it has long been recognized that the epithelium is altered in COPD, there has been little focus on targeting it to modify the disease course. Therefore, mechanisms that disrupt epithelial cell function in patients with COPD are poorly understood. In this study, we sought to determine whether epigenetic reprogramming of the cell-cell adhesion molecule E-cadherin, encoded by the CDH1 gene, disrupts epithelial integrity. By reducing these epigenetic marks, we can restore epithelial integrity and rescue alveolar airspace destruction. We used differentiated normal and COPD-derived primary human airway epithelial cells, genetically manipulated mouse tracheal epithelial cells, and mouse and human precision-cut lung slices to assess the effects of epigenetic reprogramming. We show that the loss of CDH1 in COPD is due to increased DNA methylation site at the CDH1 enhancer D through the downregulation of the ten-eleven translocase methylcytosine dioxygenase (TET) enzyme TET1. Increased DNA methylation at the enhancer D region decreases the enrichment of RNA polymerase II binding. Remarkably, treatment of human precision-cut slices derived from patients with COPD with the DNA demethylation agent 5-aza-2′-deoxycytidine decreased cell damage and reduced air space enlargement in the diseased tissue. Here, we present a novel mechanism that targets epigenetic modifications to reverse the tissue remodeling in human COPD lungs and serves as a proof of concept for developing a disease-modifying target.


  • Leptin Induces Epigenetic Regulation of Transient Receptor Potential Melastatin 7 in Rat Adrenal Pheochromocytoma Cells

    by Bonnie Ho-Yee Yeung, Kelly Griffiths, Liron Berger, Omkar Paudel, Mi-Kyung Shin, Liangyou Rui, James S. K. Sham, Vsevolod Y. Polotsky, Wan-Yee Tang

    Obesity elevates the plasma level of leptin, which has been associated with hypertension. Our recent studies in mice demonstrated that leptin increases blood pressure by activating the carotid sinus nerve, which transmits the chemosensory input from carotid bodies (CBs) to the medullary centers, and that the effect of leptin is mediated via Trpm7 (TRP [transient receptor potential] melastatin 7) channels in CB glomus cells. We also found that Trpm7 overexpression and Trpm7 promoter demethylation in CBs correlate positively with the hyperleptinemia and leptin receptor overexpression in CBs. Hence, we postulated that leptin epigenetically regulates Trpm7 expression in CBs. We addressed our hypothesis by using rat adrenal pheochromocytoma (PC12) cells as a model of CB glomus cells. PC12 cells expressing LEPRb (long, active form of leptin receptor) showed dramatic induction of the promoter activity and expression of Trpm7 upon leptin treatment. The increased Trpm7 expression coincided with the reduction of CpG site–specific methylation and trimethylation of H3K27 (H3 [histone 3] K27 [lysine 27]) and the increase of acetylation of H3K27 and trimethylation of H3K4 (H3 lysine 4) at the Trpm7 promoter. The inhibitor of STAT3 (signal transducer and activator of transcription 3) signaling, SD1008, reversed the leptin-induced Trpm7 promoter activity via modulations of the binding of pSTAT3 (phosphorylated STAT3) and DNMT3B (DNA methyltransferase 3B) and modifications of H3K27 and H3K4 at the Trpm7 promoter. Our results suggest that leptin-activated pSTAT3 epigenetically regulates the transcription of Trpm7 through DNA methylation and histone modifications. Because epigenetic changes are reversible, targeting epigenetic modifications of Trpm7 may serve as a new therapeutic approach for the treatment of hypertension in obesity.


  • Open Access

    Blockade of Trpm7 in the Carotid Body area reversed Obesity‐Induced Hypertension

    by Mi‐Kyung Shin, Chenjuan Gu, Lenise Kim, Bonnie Yeung, Rachel Lee, Luu Pham, Wan‐Yee Tang, James Sham, Vsevolod Polotsky

    Rationale: Obesity leads to cardiovascular morbidity and mortality acting via multiple mechanisms including hypertension. One of the mechanisms of obesity‐induced hypertension is an adipocyte‐produced hormone leptin, which activates the sympathetic nervous system. We have recently reported that acute leptin infusion induces hypertension acting via the TRPM7 cation channel in the carotid bodies (CB). Here, we examined the relevance of TRPM7 signaling in CB for the pathogenesis of hypertension in diet‐induced obesity (DIO) with high circulating leptin levels. We hypothesize that DIO causes hypertension acting on CB TRPM7. Methods: DIO male mice (n =11) were implanted with telemetry in the left femoral artery for continuous blood pressure monitoring. Trpm7 was silenced in the carotid body areas by transfection with Ad‐Trpm7 shRNA (n = 6); control mice (N = 5) were transfected with Ad‐CON‐shRNA . Plasma leptin level were measured by ELISA before and after tranfection; RT‐PCR was performed to confirm Trpm7 knockdown. Result: Trpm7 shRNA group induced a decrease in Trpm7 mRNA expression in the CB compared to control (0.089±0.02 vs 0.416±0.08 relatively to a house‐keeping gene Rpl19 respectively, p ). In Trpm7 shRNA treated group, blood pressure decreased from 119.0±2.2 mmHg to 109.6±1.4 mmHg ( p ), whereas scrambled shRNA had no effect (from 114.8±0.9 mmHg to 116.3±2.6 mmHg) (Fig. 1). Both groups had similar levels of plasma leptin at baseline, which did not change after transfection. Conclusion: Our study has shown that downregulation of Trpm7 in carotid bodies abolished hypertension in obese mice.

  • Open Access

    Multigenerational Epigenetic Regulation of Allergic Diseases: Utilizing an Experimental Dust Mite-Induced Asthma Model

    by Jairus C. Pulczinski, Yan Shang, Tyna Dao, Nathachit Limjunyawong, Qinying Sun, Wayne Mitzner, Robert Ys Cheng, Wan-Yee Tang

    Environmental exposures have been linked to increased asthma risk, particularly during pregnancy and in early life. Here we use a mouse model of allergic lung disease to examine the effects of pre- and perinatal house dust mite (HDM) allergen exposure on offspring phenotypic and transcriptional outcomes in three generations. We show that maternal HDM exposure (F0) acts synergistically with adult HDM exposure, leading to enhanced airway hyperresponsiveness (AHR) and lung inflammation when compared to mice exposed solely in adulthood. Additionally, a subset of F1 males were not challenged in adulthood, and used to generate F2 progeny, which was then used to generate F3 progeny. Upon adult challenge to HDM, F2, and F3 males generated from the maternal HDM (F0) exposure lineage displayed increased airway reactivity and inflammation when compared to mice exposed solely in adulthood. These findings indicate that maternal allergen exposure is capable of enhancing either susceptibly to or severity of allergic airway disease. To examine the role of epigenetic inheritance of asthma susceptibility induced by maternal HDM exposure, we utilized a genome-wide MeDIP-seq and hMeDIP-seq analysis to identify genes differentially methylated (DMG) and hydroxymethylated (DHG), and their association with the enhanced AHR. In addition, we validated the relationship between DNA methylation and mRNA expression of the DMGs and DHGs in the male sub-generations (F1-F3). We found the expression of Kchn1, Nron, and Spag17 to be differentially hydroxymethylated and upregulated in the F1 exposed to HDM both in early life and in adulthood when compared to F1 mice exposed solely in adulthood. Kcnh1 remained upregulated in the F2 and F3 from the maternal HDM (F0) exposure lineage, when compared to F1 mice exposed solely in adulthood. In summary, we demonstrated that maternal HDM exposure in early life can alter the gene expression and phenotype of offspring upon adult HDM exposure, resulting in more severe disease. These effects persist at least two generations past the initial insult, transmitted along the paternal line.


  • Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    by Bonnie H. Y. Yeung, Jessie Huang, Steven S. An, Julian Solway, Wayne Mitzner, Wan-Yee Tang

    Global DNA hydroxymethylation mediated by the TET (ten-eleven translocation) enzyme was induced in allergen-induced airway hyperresponsiveness in mouse lung tissues and specifically in isolated airway smooth muscle (ASM) cells. TET is an α-ketoglutarate (α-KG)–dependent enzyme, and the production of α-KG is catalyzed by IDH (isocitrate dehydrogenase). However, the role of IDH in the regulation of DNA hydroxymethylation in ASM cells is unknown. In comparison with nonasthmatic cells, asthmatic ASM cells exhibited higher TET activity and IDH2 (but not IDH-1 or IDH-3) gene expression levels. We modified the expression of IDH2 in ASM cells from humans with asthma by siRNA and examined the α-KG levels, TET activity, global DNA hydroxymethylation, cell proliferation, and expression of ASM phenotypic genes. Inhibition of IDH2 in asthmatic ASM cells decreased the α-KG levels, TET activity, and global DNA hydroxymethylation, and reversed the aberrant ASM phenotypes (including decreased cell proliferation and ASM phenotypic gene expression). Specifically, asthmatic cells transfected with siRNA against IDH2 showed decreased 5hmC (5-hydroxymethylcytosine) levels at the TGFB2 (transforming growth factor-β2) promoter determined by oxidative bisulfite sequencing. Taken together, our findings reveal that IDH2 plays an important role in the epigenetic regulation of ASM phenotypic changes in asthmatic ASM cells, suggesting that IDH2 is a potential therapeutic target for reversing the abnormal phenotypes seen in asthma.


  • Can social support during pregnancy affect maternal DNA methylation? Findings from a cohort of African-Americans

    by Pamela J. Surkan, Xiumei Hong, Boyang Zhang, Nobutoshi Nawa, Hongkai Ji, Wan-Yee Tang, Yuelong Ji, Mary C. Kimmel, Guoying Wang, Colleen Pearson, et al.

    Background While stress and the absence of social support during pregnancy have been linked to poor health outcomes, the underlying biological mechanisms are unclear. Methods We examined whether adverse experiences during pregnancy alter DNA methylation (DNAm) in maternal epigenomes. Analyses included 250 African-American mothers from the Boston Birth Cohort. Genome-wide DNAm profiling was performed in maternal blood collected after delivery, using the Infinium HumanMethylation450 Beadchip. Linear regression models, with adjustment of pertinent covariates, were applied. Results While self-reported maternal psychosocial lifetime stress and stress during pregnancy was not associated with DNAm alterations, we found that absence of support from the baby's father was significantly associated with maternal DNAm changes inTOR3A, IQCB1,C7orf36, andMYH7Band that lack of support from family and friends was associated with maternal DNA hypermethylation on multiple genes, includingPRDM16andBANKL. Conclusions This study provides intriguing results suggesting biological embedding of social support during pregnancy on maternal DNAm, warranting additional investigation, and replication.